CHOP方案治疗复发性非何杰金氏淋巴瘤38例近期疗效分析

胡东霞; 何家林

CHOP方案治疗复发性非何杰金氏淋巴瘤38例近期疗效分析

胡东霞¹,
何家林²

1. 武汉铁路中心医院血液病内科, 430068;2. 湖北省肿瘤医院

详细信息

中图分类号: R733
计量
- 文章访问数: 911
- HTML全文浏览量: 48
- PDF下载量: 400
出版历程
- 刊出日期: 1997-02-04

Treatment of Recurrent Non-Hodgkin's Lymphoma (NHL) With CHOP Regimen-Observation of the Short-term Curative Effect in 38 Cases

Hu Dong-xia¹,

Wuhan Railway Central Hospital, Wuhan 430068

摘要

摘要: 本文报道CHOP方案治疗38例复发性非何杰金氏淋巴瘤（NHL）的结果，全部病例均经病理组织学证实。按成都会议方案属中、高度恶性者78．9%，Ⅲ、Ⅳ期病人占65．8%。均经CHOP方案化疗4～11疗程，6疗程以上者占71%，8例加用其它一些抗癌药，9例化疗后予以放疗或手术切除。全组总的缓解率71%，完全缓解率31%，中位缓解期10．3个月。主要毒副反应为消化道反应、白细胞减少及脱发，一般病人都可耐受。作者认为，CHOP方案是一个安全有效的化疗方案，可用于复发性NHL的治疗。
- CHOP方案 /
- 化疗 /
- 非何杰金氏淋巴瘤 /
- 复发
Abstract: The results of chemotherapy with CHOP regimen in 38 recurrent patients of NHL, all pathologically confirmed, were reported. 78.9% of the cases were medi-an-grade or high-grade malignant lymphoma according to Chendo meet's classifica-tions schedule NHL conducted classification (1985), 65.8% of the cases at Ⅲ, Ⅳ stage. The therapy time for the patients treated by CHOP regimen were 4~11 courses, 70% of the cases over 6 courses. All patients were treated by CHOP regi-men,8 cases also applied the other anticarcinogenic drugs, and 9 cases underwent adjuvant radiotherapy or surgient therapy to the residual disease following chemotherapy. The result for the whole group, total response rate was 71%, com-pleted remission rate 31%, and MTS 10.3M. The main side effects including gas-trointestinal toxicity, leucopenia and alopecia were not serve . The authors believe that CHOP is a safe, effective regimen for the patients with relaped case of NHL.
- CHOP regimen /
- Chemotherapy /
- Non-Hodgkin's lymphoma /
- Recurrent

HTML全文

参考文献(4)

[1]	黄雪珍, 毛雪芹, 吴晕, 等. ProMACE-MOPP方案治疗NHL(附56例分析). 实用肿瘤杂志, 1992, 7(3): 160.
[2]	江伟, 祝浩强, 张一欧, 等. CHOP与BEPPA交替治疗进展型恶性淋巴瘤17例近期疗效观察. 癌症, 1991, 10(6): 511.
[3]	管忠震, 喻俪华, 何友谦, 等. 用CHOP方案治疗NHL103例临床疗效及毒性观察. 癌症, 1989, 8(2): 98.
[4]	刘淑真, 宋晓红, 杨蔚置, 等. CHOP方案治疗NHL近期疗效分析. 河南肿瘤学杂志, 1993, 6(4): 301.